Novavax (NVAX) Gross Profit Growth (1y) (2012 - 2026)
Novavax (NVAX) Gross Profit Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 41.37% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 7.76% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 16.94% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 68.41% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Novavax | 1.23 Bn | 440.77 Mn | 108.82 Mn | -83.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -83.32% |
| Dec 31, 2025 | 142.12% |
| Sep 30, 2025 | 104.87% |
| Jun 30, 2025 | -56.76% |
| Mar 31, 2025 | 1,783.45% |
| Dec 31, 2024 | -62.13% |
| Sep 30, 2024 | -72.87% |
| Jun 30, 2024 | 0.16% |
| Mar 31, 2024 | -26.07% |
| Dec 31, 2023 | -22.36% |
| Sep 30, 2023 | -70.65% |
| Jun 30, 2023 | 532.93% |
| Mar 31, 2023 | -93.20% |
| Dec 31, 2022 | -20.96% |
| Sep 30, 2022 | 67.74% |
| Jun 30, 2022 | -128.57% |
| Mar 31, 2022 | 54.01% |
| Sep 30, 2015 | -9.77% |
| Jun 30, 2015 | 258.22% |
| Mar 31, 2015 | 67.03% |